Search

Search Results

• 

  Duration of treatment for osteoporosis

  Luca Idolazzi, A. Fassio, D. Gatti, S. Tamanini, O. Viapiana, M. Rossini, S. Adami

  22-35

  28-03-2013

  https://doi.org/10.4081/reumatismo.2013.22

  3559

  PDF: 1241
• 

  Prevention and treatment of glucocorticoid-induced osteoporosis in International and Italian scenarios

  O. Di Munno, A. Delle Sedie

  67-79

  https://doi.org/10.4081/reumatismo.2011.67

  1558

  PDF: 923
• 

  Different fracture risk profile in patients treated with anti-osteoporotic drugs in real-life

  G. Adami, A. Giollo, M. Rossini, G. Orsolini, C. Benini, O. Viapiana, D. Gatti, A. Fassio

  71-74

  23-07-2020

  https://doi.org/10.4081/reumatismo.2020.1267

  1511

  PDF: 1063

• The role of rank-ligand inhibition in the treatment of postmenopausal osteoporosis

  M. Varenna, D. Gatti

  163-171

  https://doi.org/10.4081/reumatismo.2010.163

  1759

  PDF: 1182

• Anabolic therapy in b-thalassaemia major induced osteoporosis: case report and literature review

  A. Trotta, A. Corrado, F.P. Cantatore

  119-126

  https://doi.org/10.4081/reumatismo.2010.119

  1367

  PDF: 1982

• Glucocorticoid-induced osteoporosis and rheumatic diseases. Pathogenesis, prevention and treatment

  Ombretta Di Munno, Andrea Delle Sedie

  11-21

  https://doi.org/10.4081/reumatismo.2006.11

  1115

  PDF: 1517